Related Experiment Video
Updated: Jun 21, 2026
08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis
E Portaccio1, M L Stromillo, B Goretti
1Department of Neurology, University of Florence, Italy.
Neurology
|July 31, 2009
Summary
Neuropsychological tests and MRI scans can predict disease progression in benign multiple sclerosis (B-MS). This helps identify patients who may no longer be benign, improving B-MS management.
Area of Science:
- Neurology
- Neuroimaging
- Neuropsychology
Background:
- The definition of benign multiple sclerosis (B-MS) remains debated.
- Neuropsychological tests and MRI measures offer insights into B-MS interpretation.
Purpose of the Study:
- To evaluate neuropsychological tests and MRI measures as predictors of short-term disease evolution in B-MS patients.
- To refine the identification and understanding of benign multiple sclerosis.
Main Methods:
- Sixty-three B-MS patients underwent neuropsychological testing and MRI (conventional and MT imaging).
- Evaluated white matter lesions, brain volumes, and MT ratio.
- Patients were followed for 5 years to assess disease status (benign vs. no longer benign - NLB).
Main Results:
- 29% of patients transitioned to NLB status within 5 years.
- Male gender, number of failed neuropsychological tests, and T1-weighted lesions predicted NLB status.
- A model combining these factors achieved 82% accuracy in predicting NLB status.
Conclusions:
- Cognitive assessment and MRI metrics are effective predictors of short-term disease progression in B-MS.
- These findings aid in the accurate identification of patients with benign multiple sclerosis.
